期刊文献+

人绒毛膜促性腺激素的特性及其临床应用 被引量:14

原文传递
导出
摘要 人绒毛膜促性腺激素(hCG)是糖蛋白激素家族中的一员,一旦妊娠后绒毛生成,即可在血循环中检测到。hCG在正常与异常妊娠期有一定的分泌规律,滋养细胞的数量和活力与hCG的分泌密切相关,因此,血清hCG测定能够在临床上诊断早孕、异位妊娠、先兆流产、葡萄胎及妊娠滋养细胞肿瘤(GTN)等,并在治疗中和治疗后的随诊中成为重要监测指标。本文就hCG的结构、功能及其临床应用进行综述。
作者 赵峻 向阳
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2008年第1期69-71,共3页 Chinese Journal of Obstetrics and Gynecology
  • 相关文献

参考文献19

  • 1Stenman UH, Tiitinen A, Alfthan H, et al. The classification, functions and clinical use of different isoforms of HCG. Hum Reprod Update, 2006, 12:769 -784.
  • 2Cole LA, Sutton JM. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer. J Reprod Med, 2004, 49:545-553.
  • 3Seki K, Matsui H, Sekiya S. Advances in the clinical laboratory detection of gestational trophoblastic disease. Clin Chim Acta, 2004, 349:1-13.
  • 4McChesney R, Wilcox AJ, O'Connor JF, et al. Intact HCG, free HCG beta subunit and HCG beta core fragment: longitudinal patterns in urine during early pregnancy. Hum Reprod, 2005,20 : 928 -935.
  • 5Butler SA, lles RK. The free monomeric beta subunit of human chorionic gonadotrophin (hCG beta) and the recently identified homodimeric beta-beta subunit (hCG beta beta ) both have autocrine growth effects. Tumour Biol, 2004, 25 : 18-23.
  • 6Behtash N, Ghaemmaghami F, Honar H, et al. Is normal betahCG regression curve helpful in the diagnosis of persistent trophoblastic disease? Int J Gynecol Cancer, 2004, 14:980-983.
  • 7王小平,向阳,张德永,杨秀玉,张浩,刘欣.化学发光法测定绒毛膜促性腺激素游离β亚单位对滋养细胞疾病的诊断价值[J].中国实用妇科与产科杂志,2001,17(11):660-662. 被引量:16
  • 8Cole LA, Khanlian SA, Muller CY, et al. Gestational trophoblastie diseases: 3. Human ehorionie gonadotropin-free betasubunit, a reliable marker of placental site trophoblastic tumors. Gynecol Oncol, 2006, 102 : 160-164.
  • 9Kohom El, Cole L Nicked human chorionic gonadotropin in trophoblastic disease. Int J Gynecol Cancer, 2000, 10:330-335.
  • 10Zavadil M, Feyereisl J, Safar P, et al. Syndrome of persistent low levels of human chorionic gonadotrophin (hCG). Ceska Gynekol, 2006, 71:136-142.

二级参考文献8

  • 1[1]Tyrey L. Human chorionic gonadotropin: properties and assay methods. Semi Oncol, 1995, 22(2): 121
  • 2[2]Vaitukaitis JL, Brounstein GD, Ross GT. A radioimmunoassay which specificall y measures human chorionic gonadotropin in the presence of human luteinizing hor mone. Am J Obstet Gynecol, 1972,113(7):751
  • 3[3]Badonnel Y, Barbe F, Legagneur H, et al. Inhibin as a marker for hydatidifor m mole: a comparative study with the determinations of intact human chorionic go nadotrophin and its free B-subunit. Clin Endocrinol, 1994, 41(2):155
  • 4[4]Alfhan H, Stenman U. Pathophysiological importance of various molecular forms of human choriogonadotropin. Mol Cell Endocrinol,1996,125(12):107
  • 5[5]Cole A. HCG,its free subunits and its metabolites roles in pregnancy and tr ophoblastic disease. J Reprod Med, 1998,43(1):3
  • 6[6]Ozturk M, Bellet D, Manil L, et al. Physiological studies of human chorionic gonadotropin(HCG), αHCG and βHCG as measured by specific monoclonal immunorad iometric assay. Endocrinology, 1987,120(2):549
  • 7[7]Wide L, Johannisson E, Tillinger K, et al. Metabolic clearance of human chor ionic gonadotrophin administered to non-pregnant women. Acta Endocrinol, 1968, 5 9(4): 579
  • 8[8]Wehmann RE ,Nisula BC. Metabolic and renal clearance rates of purified human chorionic gonadotropin. J Clin Invest, 1981, 38(7): 184

共引文献15

同被引文献150

引证文献14

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部